TOPLINE: Four clinical organizations jointly released a clinical advisory with evidence-based nutrition and lifestyle interventions to enhance glucagon-like peptide 1 (GLP-1) treatment outcomes for obesity. METHODOLOGY: An expert group comprised of multiple clinical and research disciplines assessed the literature to identify pragmatic priorities for nutrition and other lifestyle interventions relevant to GLP-1 treatment for obesity. … Read more
Hypertension Canada has released a guideline that aims to enhance the standard of hypertension management in primary care settings with evidence-based, pragmatic, and easy-to-implement recommendations. The guidance is based on the World Health Organization’s HEARTS framework to improve hypertension control and reduce cardiovascular burden. The previous guideline was published in 2020. “For the 2025 guideline, … Read more
ORLANDO, Fla. — A program at Duke University School of Nursing, Durham, North Carolina, is currently one of just two in the United States that trains nurse practitioners (NPs) to provide endocrine specialty care, but more could be on the way. Established in 2016, the program was “a result of national demand for diabetes and … Read more
Medically supervised resistance training and adequate protein intake may help minimize the loss of lean body mass in people taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for weight loss, new data suggest. The findings came from a prospective 6-month study of 200 adults with overweight or obesity who received education on resistance training and … Read more
Are you tired of the one-size-fits-all approach to skincare? Recent advancements in the treatment of rosacea are revolutionizing how this condition is managed, emphasizing a personalized approach based on individual symptoms. Learn how new treatment algorithms are helping physicians provide more targeted and effective care for rosacea sufferers,offering hope for improved outcomes and quality of … Read more
Reflecting the growing understanding of rosacea as a continuum of systemic inflammation, new National Rosacea Society (NRS) Treatment Algorithms suggest therapies based not on the rosacea subtype but on the individual patients’ clinical signs and symptoms. The algorithms were published on the NRS website’s physician section on March 25. New Diagnostic Approach The algorithms change … Read more
TOPLINE: Most survey respondents were unaware of US Food and Drug Administration (FDA)-approved treatments for hidradenitis suppurativa (HS), and only 18% were satisfied with their current management. METHODOLOGY: Researchers developed a survey that was distributed via the HSconnect.org listserv between November and December 2023, collecting responses from participants aged ≥ 18 years with HS. A … Read more
TOPLINE: The prevalence of cerebral small vessel disease (CSVD) nearly doubled over 7.5 years in neurologically asymptomatic patients with type 1 diabetes (T1D). The progression of cerebral microbleeds (CMBs), one of the manifestations of CSVD, was associated with baseline systolic blood pressure and A1c among other factors, while the progression of white matter hyperintensities was … Read more
CHICAGO — After an application to form a new ongoing certification board for cardiologists was rejected by the American Board of Medical Specialties (ABMS) in February, cardiology leaders held a town hall session here at the American College of Cardiology (ACC) Scientific Session 2025 to hear what members think should be the next steps. Just … Read more
The first updated guidelines for seizures, driving licensure, and medical reporting in nearly two decades reflect a shift toward medical advisory boards to determine driver licensing for individuals with epilepsy and greater physician flexibility and immunity in reporting unsafe drivers. The consensus position statement was developed by experts from the American Academy of Neurology (AAN), … Read more